0001365916-20-000140.txt : 20200807 0001365916-20-000140.hdr.sgml : 20200807 20200807195739 ACCESSION NUMBER: 0001365916-20-000140 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200805 FILED AS OF DATE: 20200807 DATE AS OF CHANGE: 20200807 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Piwnica Carole CENTRAL INDEX KEY: 0001501760 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34885 FILM NUMBER: 201086294 MAIL ADDRESS: STREET 1: C/O AMYRIS, INC. STREET 2: 5885 HOLLIS ST., SUITE 100 CITY: EMERYVILLE STATE: CA ZIP: 94608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMYRIS, INC. CENTRAL INDEX KEY: 0001365916 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 550856151 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5885 HOLLIS STREET, SUITE 100 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 510-450-0761 MAIL ADDRESS: STREET 1: 5885 HOLLIS STREET, SUITE 100 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: AMYRIS BIOTECHNOLOGIES INC DATE OF NAME CHANGE: 20060613 4 1 wf-form4_159684463830197.xml FORM 4 X0306 4 2020-08-05 0 0001365916 AMYRIS, INC. AMRS 0001501760 Piwnica Carole C/O AMYRIS, INC. 5885 HOLLIS STREET, SUITE 100 EMERYVILLE CA 94608 1 0 0 0 Common Stock 2020-08-05 4 A 0 2266 0 A 10064 D Common Stock 1372634 I by Naxyris S.A. Warrant (Right to Buy) 4.94 2020-08-05 4 A 0 3466 0 A 2030-08-05 Common Stock 3466.0 3466 D Represents a restricted stock unit award that vests as to 100% of the units on August 5, 2021. Includes an additional 2,266 shares of common stock beneficially owned by the Reporting Person as reported on the Form 4 filed on October 25, 2019. Due to an unintentional error, the Form 5 filed by the Reporting Person on April 7, 2020 included the wrong number of shares beneficially owned by the Reporting Person. The Reporting Person beneficially owns securities held by Naxyris S.A. since August 22, 2019. Stock option vests as to 100% of the shares underlying the stock option on August 5, 2021. /s/ Carole Piwnica by Bruna Lawant, Attorney-in-Fact 2020-08-05